We reveal that NGS of DNA from plan FFPE endoscopic biopsy or EMR samples can be employed to detect genomic mutations in nonneoplastic BIM with higher analytical sensitivity. The ability to detect mutations in nonneoplastic mucosa, quantitatively and with large detection sensitivity, makes it achievable to implement NGS mutational tests http://cornstalkh654hii1.topbloghub.com/profile